Glenmark USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials Read more
Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts GlobalData Read more
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData Read more
Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy challenges Read more
